Pharmaceutical Industry News Round Up

November 10, 2006

There have been several interesting developments within the pharmaceutical industry recently:

The election results take a toll on the drug industry's share prices in expectation of increasing government regulation
The Financial Times and The Economist report on the industry's growing dependence on biotech firms
Novartis opens a research facility in Shanghai
Pfizer has opened its library of medicinal compounds to the WHO for research on neglected diseases
The U.S. News & World Report covers the new trend in biomedical philanthropy
Jamie Robinson, Ian Spatz, and Leighton Read discuss value-based pricing in the biotech sector
Joseph Stiglitz (.pdf) weighs in on the "prizes versus patents" debate

Disclaimer

CGD blog posts reflect the views of the authors, drawing on prior research and experience in their areas of expertise. CGD is a nonpartisan, independent organization and does not take institutional positions.